.025 semaglutide It works by controlling your appetite. Semaglutide (Month 1) 0.25mg |

Legal Information CALBIOCHEM is a registered trademark of Merck KGaA, Darmstadt, Germany Other Notes Tilly, J.L., and Tilly, K.I

Oral amycretin showed 13.1% weight loss at 12 weeks in phase 1 and up to 10.1% in phase 2 T2D

Originally developed for type 2 diabetes, semaglutide has shown promising results in weight management for individuals with or without diabetes

The overwhelming majority of side effects are temporary, improving significantly within weeks as your body adapts to each dose level

The meta-regression shows that after 1 year of treatment withdrawal, participants regain 60% of the weight they lost during treatment